Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities
Sign Up to like & getrecommendations! Published in 2019 at "CNS Spectrums"
DOI: 10.1017/s109285291900124x
Abstract: Schizophrenia remains one of the most severe medical diseases. Current dopamine modulating first-generation and second-generation antipsychotics target mainly positive symptoms, but not/inadequately negative and cognitive symptoms. Additional challenges include non-adherence and adverse effects, especially cardiometabolic… read more here.
Keywords: positive symptoms; review; keeping therapeutic; emerging pharmacological ... See more keywords